Dalhousie University offers Pharmacology (PhD), a doctorate in Pharmacy programme in Halifax, Canada. The programme runs for 5 years, delivered on campus. Tuition for international students is CAD 7,338 per year (CAD 7,338 per year for local students).
At a glance
Degree:Doctorate
Field:Pharmacy
Duration: 5 years
Delivery: On Campus
Local tuition: CAD 7,338 / year
International tuition: CAD 7,338 / year
We have no an application deadline on record for this programme yet — see the official programme page.
— it helps other students.
The Doctor of Philosophy in Pharmacology at Dalhousie University's Faculty of Medicine prepares researchers to design and carry out independent studies into how drugs and other chemical agents act on biological systems. The program is delivered collaboratively between the Department of Pharmacology and the Faculty of Graduate Studies, combining coursework with an original, supervised research project that culminates in a doctoral dissertation. It is offered full-time and delivered in person in Halifax, with intakes in September and January and a standard length of five years or longer to completion. Graduates are prepared for research careers in academic, government, and industry settings, including pharmaceutical research and development. Admission requires applicants to meet Dalhousie's Faculty of Graduate Studies minimum entrance requirements together with the Department of Pharmacology's own program-specific admission criteria.
Requirements
Minimum GPA:3.00 / 4.0
Admission Requirements: Applicants must meet Dalhousie University's Faculty of Graduate Studies minimum entrance requirements, which include a minimum grade point average of 3.0 (a B average) on a 4.0 scale in the final 60 credit hours of a relevant degree, as well as the Department of Pharmacology's own program-specific admission criteria. Applicants whose first language is not English must meet Dalhousie's English language proficiency requirements for graduate applicants, such as an IELTS Academic score of 7.0 or a TOEFL iBT score of 92 (or 4.5 on the 1-6 scale used from January 2026).
